EUVIMEDEUVIMED entdecken
Open Access

Genomic Profiling of Thyroid Nodules: Current Role for ThyroSeq Next-Generation Sequencing on Clinical Decision-Making

Atil Y Kargi, Marcela Perez Bustamante, Seza Gulec

Molecular Imaging and Radionuclide Therapy · 2017

DOI: 10.4274/2017.26.suppl.04 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Imaging and Radionuclide Therapy, 2017. Verfasst von Atil Y Kargi und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Miami Hospital, Clinic of Diabetes and Metabolism, Division of Endocrinology, Florida, USA, Phone: 305-243-3636, E-mail: akargi@med.mia…. Die Arbeit wurde bisher 16-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • University of Miami Hospital, Clinic of Diabetes and Metabolism, Division of Endocrinology, Florida, USA, Phone: 305-243-3636, E-mail: akargi@med.miami.edu.

Zitieren

APA

Kargi, A. Y., Bustamante, M. P., & Gulec, S. (2017). Genomic Profiling of Thyroid Nodules: Current Role for ThyroSeq Next-Generation Sequencing on Clinical Decision-Making. Molecular Imaging and Radionuclide Therapy. https://doi.org/10.4274/2017.26.suppl.04

Vancouver

Kargi AY, Bustamante MP, Gulec S. Genomic Profiling of Thyroid Nodules: Current Role for ThyroSeq Next-Generation Sequencing on Clinical Decision-Making. Molecular Imaging and Radionuclide Therapy. 2017. doi:10.4274/2017.26.suppl.04

BibTeX
@article{Kargi2017,
  author = {Kargi, Atil Y and Bustamante, Marcela Perez and Gulec, Seza},
  title = {Genomic Profiling of Thyroid Nodules: Current Role for ThyroSeq Next-Generation Sequencing on Clinical Decision-Making},
  journal = {Molecular Imaging and Radionuclide Therapy},
  year = {2017},
  doi = {10.4274/2017.26.suppl.04}
}
Kostenlos starten →